BETA-INTERFERON-1a (Avonex®)
Clinical Indication
Multiple sclerosis in adults
Comments
In line with NICE TA 527
Implementation date 27th September 2018
Date of classification
August 2018
Review date
August 2021
Red
Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).